STRATEGAMY LLC: public contracts won without a rival in United States: 3 uncontested awards; 75% of its awards; 3 without a competition; 0 single bid.
Assay record ASY-US-1J5QSBE1CC · Cite as: Assay Systems, “STRATEGAMY LLC: public contracts won without a rival in United States”, https://assay-systems.com/register/us/uncontested/s/strategamy-llc/
STRATEGAMY LLC won 3 of its 4 public contract awards in United States without a rival from 2024-09-23 to 2026-09-30, worth $7.4M: 3 without a competition and 0 after a competition that drew a single bid. 1 buyer awarded it without a rival, the largest Food and Drug Administration with 3.
An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.
Food and Drug Administration gave STRATEGAMY LLC 4 awards: 3 without a competition, 0 after a competition with a single bid. First 2024-09-23, latest 2026-09-30.
| Date | Buyer | How | Value | Stated reason |
|---|---|---|---|---|
| 2026-09-21 | Food and Drug Administration 75F40126C00166 | No competition NOT AVAILABLE FOR COMPETITION | $2.5M | AUTHORIZED BY STATUTE (FAR 6.302-5(A)(2)(I)) |
| 2025-09-26 | Food and Drug Administration 75F40125C00100 | No competition NOT AVAILABLE FOR COMPETITION | $3.3M | AUTHORIZED BY STATUTE (FAR 6.302-5(A)(2)(I)) |
| 2024-09-23 | Food and Drug Administration 75F40123C00189 | No competition NOT AVAILABLE FOR COMPETITION | $1.6M | AUTHORIZED BY STATUTE (FAR 6.302-5(A)(2)(I)) |
Every uncontested award in United States · All countries · STRATEGAMY LLC in the register
Source: USAspending.gov prime award transactions (contracts). Awards are matched to their buyer and supplier as published. Updated 17 October 2026.